Do African American men have lower survival from prostate cancer compared with White men? A meta-analysis.
作者： Gayathri Sridhar , Saba W. Masho , Tilahun Adera , Viswanathan Ramakrishnan , John D. Roberts
关键词:
摘要: Prostate cancer is the second leading cause of cancer-related mortality in men. This meta-analysis was conducted to investigate relationship between race and survival from prostate cancer. A systematic review articles published 1968 2007 assessing conducted. Analysis unadjusted studies reported that African American men have an increased risk all-cause (hazard ratio [HR] = 1.47, 95% confidence interval [CI] 1.31-1.65, p < .001). However, examination adjusted identified no difference (HR 1.07, CI 0.94-1.22, .308). No statistically significant observed cancer-specific both analyses using 1.11, 0.94-1.31, .209) 1.15, 0.95-1.41, .157). concludes there are racial differences overall White
cabdirect.org
sagepub.com
sci-hub.se 参考文章(48)
Christopher G Wood, Edilberto Ramirez, Reena B. Wyatt, Curtis A Pettaway, Ricardo F. Sánchez-Ortiz, Christopher J Logothetis, Prognostic factors for survival among Caucasian, African-American and Hispanic men with androgen-independent prostate cancer. Journal of The National Medical Association. ,vol. 96, pp. 1587- 1593 ,(2004)
E. David Crawford, Brent A. Blumenstein, Phyllis J. Goodman, Marilyn A. Davis, Mario A. Eisenberger, David G. McLeod, Joseph T. Spaulding, Ralph Benson, F. Andrew Dorr, Leuprolide with and without flutamide in advanced prostate cancer. Cancer. ,vol. 66, pp. 1039- 1044 ,(1990) , 10.1002/CNCR.1990.66.S5.1039
M. Roach, Is race an independent prognostic factor for survival from prostate cancer Journal of The National Medical Association. ,vol. 90, ,(1998)
Sander Greenland, Invited Commentary: A Critical Look at Some Popular Meta-Analytic Methods American Journal of Epidemiology. ,vol. 140, pp. 290- 296 ,(1994) , 10.1093/OXFORDJOURNALS.AJE.A117248
Deepak Khuntia, Chandana A. Reddy, Arul Mahadevan, Eric A. Klein, Patrick A. Kupelian, Recurrence-free survival rates after external-beam radiotherapy for patients with clinical T1-T3 prostate carcinoma in the prostate-specific antigen era: what should we expect? Cancer. ,vol. 100, pp. 1283- 1292 ,(2004) , 10.1002/CNCR.20093
Hari H. Dayal, C. Chiu, Factors associated with racial differences in survival for prostatic carcinoma. Journal of Chronic Diseases. ,vol. 35, pp. 553- 560 ,(1982) , 10.1016/0021-9681(82)90074-1
David G. McLeod, Paul F. Schellhammer, Nicholas J. Vogelzang, Mark S. Soloway, Rooholloh Sharifi, Norman L. Block, Peter M. Venner, A. Lynn Patterson, Michael F. Sarosdy, R. Patrick Kelley, Geert J.C.M. Kolvenbag, , Exploratory analysis on the effect of race on clinical outcome in patients with advanced prostate cancer receiving bicalutamide or flutamide, each in combination with LHRH analogues The Prostate. ,vol. 40, pp. 218- 224 ,(1999) , 10.1002/(SICI)1097-0045(19990901)40:4<218::AID-PROS2>3.0.CO;2-6
Donna F Stroup, Jesse A Berlin, Sally C Morton, Ingram Olkin, G David Williamson, Drummond Rennie, David Moher, Betsy J Becker, Theresa Ann Sipe, Stephen B Thacker, Meta-analysis of Observational Studies in EpidemiologyA Proposal for Reporting JAMA. ,vol. 283, pp. 2008- 2012 ,(2000) , 10.1001/JAMA.283.15.2008
Isaac J. Powell, Kendra Schwartz, Maha Hussain, Removal of the financial barrier to health care: Does it impact on prostate cancer at presentation and survival? A comparative study between black and white men in a Veterans Affairs system Urology. ,vol. 46, pp. 825- 830 ,(1995) , 10.1016/S0090-4295(99)80352-5
Christophe E. Iselin, James W. Box, Robin T. Vollmer, Lester J. Layfield, Judith E. Robertson, David F. Paulson, Surgical control of clinically localized prostate carcinoma is equivalent in African-American and white males Cancer. ,vol. 83, pp. 2353- 2360 ,(1998) , 10.1002/(SICI)1097-0142(19981201)83:11<2353::AID-CNCR15>3.0.CO;2-L